InvestorsHub Logo

HappyLibrarian

04/14/24 12:39 PM

#685134 RE: Nemesis18 #685130

The quote you provided did not come from me but from someone else’s post.

Please refrain from false attributions, especially when you put the word ‘fact’ in all caps. If you are going to quote someone else in a post to me, say who you’re quoting so people do not think it comes from the person you’re replying to.

In any case, the fact that you are stooping to this nonsense tells me it’s time for me to leave the NWBO discussion alone for a while and go back to waiting (hopefully not on Gidot).

Smitty5150

04/14/24 5:39 PM

#685168 RE: Nemesis18 #685130

"Conclusions
This phase 3, nonrandomized, externally controlled trial found
that the addition of DCVax-L to SOC was associated with a clinically meaningful and statistically significant extension of overall survival in both nGBM and rGBM. Treatment with DCVax-L
also had an excellent safety profile and noteworthy tails of longterm survival curves."


https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847

Sorry, but I will believe the 60+ Authors, who are the experts, over a anonymous message board poster, who has nothing better to do with his time than warning us poor retail investors of the perils of investing in NW Bio.